e-learning
resources
London 2016
Sunday, 04.09.2016
Role of genetics and exposures in COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Variants of apelin gene and COPD
Ender Coşkunpınar (Istanbul, Turkey), Ender Coskunpinar, Engin Aynaci, Abdullah Melekoglu, Pinar Yildiz
Source:
International Congress 2016 – Role of genetics and exposures in COPD and asthma
Session:
Role of genetics and exposures in COPD and asthma
Session type:
Thematic Poster
Number:
1206
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ender Coşkunpınar (Istanbul, Turkey), Ender Coskunpinar, Engin Aynaci, Abdullah Melekoglu, Pinar Yildiz. Variants of apelin gene and COPD. Eur Respir J 2016; 48: Suppl. 60, 1206
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
SP-D as a biomarker for COPD in the Lebanese population
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014
Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
MMP-3 serum levels and
MMP3
-1171insA promoter polymorphism in patients with COPD
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
Adrenomedullin optimizes mortality prediction in COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Serum sirtuin-1 is reduced in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Periostin and TSLP: New markers useful in diagnosis of obstructive lung disease
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Polymorphism of collagen I gene and risk of chronic obstructive pulmonary disease associated with ischemic heart disease
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Distribution of blood eosinophil in COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
A multimarker approach to identify atherosclerosis in COPD
Source: International Congress 2014 – Markers
Year: 2014
Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Proteinase-inhibitor system state in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept